Trivalent chromium alleviates oleic acid induced steatosis in SMMC-7721 cells by decreasing fatty acid uptake and triglyceride synthesis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biometals

• Publication date

  2016-08-06

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s10534-016-9960-2PMID 27497686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• F3MB(PANDER) Decreases Mice Hepatic Triglyceride and Is Associated with Decreased DGAT1 Expression

  2015cited by this paper
• Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice.

  2015cited by this paper
• Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study

  2015cited by this paper
• A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma

  2015cited by this paper
• Roles of Acyl-CoA: Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes

  2015cited by this paper
• Treatment of rats with Jiangzhi Capsule improves liquid fructose-induced fatty liver: modulation of hepatic expression of SREBP-1c and DGAT-2

  2015cited by this paper
• Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.

  2015cited by this paper
• The role of glycerol-3-phosphate dehydrogenase 1 in the progression of fatty liver after acute ethanol administration in mice.

  2014cited by this paper
• PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.

  2014cited by this paper
• CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis[S]

  2014cited by this paper
• Effect of Oleic Acid on the Levels of Eight Metal Ions in Human Hepatoma SMMC-7721 Cells

  2014cited by this paper
• Chromium downregulates the expression of Acetyl CoA Carboxylase 1 gene in lipogenic tissues of domestic goats: a potential strategy for meat quality improvement.

  2014cited by this paper
• Involvement of toll-like receptor 2 and 4 in association between dyslipidemia and osteoclast differentiation in apolipoprotein E deficient rat periodontium

  2013cited by this paper
• Effects of Dietary Chromium Methionine on Growth Performance, Carcass Composition, Meat Colour and Expression of the Colour-related Gene Myoglobin of Growing-finishing Pigs

  2013cited by this paper
• Oxidized eicosapentaenoic acids more potently reduce LXRα-induced cellular triacylglycerol via suppression of SREBP-1c, PGC-1β and GPA than its intact form

  2013cited by this paper
• Involvement of free radicals and oxidative stress in NAFLD/NASH

  2013cited by this paper
• Aquaporin-9 downregulation prevents steatosis in oleic acid-induced non-alcoholic fatty liver disease cell models.

  2013cited by this paper
• Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1.

  2013cited by this paper
• Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2

  2011cited by this paper
• Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C

  2011cited by this paper
• Chromium is not an essential trace element for mammals: effects of a “low-chromium” diet

  2011cited by this paper
• A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling

  2010cited by this paper
• Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease.

  2010cited by this paper
• Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice.

  2010cited by this paper
• A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats[S]

  2010cited by this paper
• Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.

  2010cited by this paper
• Chromium attenuates hepatic damage in a rat model of chronic cholestasis.

  2009cited by this paper
• Intestinal lipid absorption.

  2009cited by this paper
• Chromium attenuates hepatic damage in a rat model of chronic cholestasis.

  2009cited by this paper
• Fatty acid metabolism: target for metabolic syndrome This work is supported by grants from the National Institute of Health (GM-63115), the Hefni Technical Training Foundation, and the Medallion Foundation. Published, JLR Papers in Press, December 1, 2008.

  2009cited by this paper
• Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway.

  2009cited by this paper
• Mechanism of action of niacin.

  2008cited by this paper
• Gender-related differences in electrocardiographic parameters and their association with cardiac events in patients after myocardial infarction.

  2008cited by this paper
• Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification

  2007cited by this paper
• Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation.

  2007cited by this paper
• Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but Not DGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance*

  2007cited by this paper
• Increased Hepatic CD36 Expression Contributes to Dyslipidemia Associated With Diet-Induced Obesity

  2007cited by this paper
• Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis*

  2006cited by this paper
• The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes

  2006cited by this paper
• Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research

  2006cited by this paper
• Alterations in hepatic gene expression by trivalent chromium in Fundulus heteroclitus.

  2006cited by this paper
• Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance.

  2005cited by this paper
• Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice

  2005cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• Lipopenia and Skin Barrier Abnormalities in DGAT2-deficient Mice*

  2004cited by this paper
• Trivalent chromium alters gene expression in the mummichog (Fundulus heteroclitus)

  2004cited by this paper
• Protective effects of 17beta-estradiol and trivalent chromium on interleukin-6 secretion, oxidative stress, and adhesion of monocytes: relevance to heart disease in postmenopausal women.

  2004cited by this paper
• Protective effects of 17β-estradiol and trivalent chromium on interleukin-6 secretion, oxidative stress, and adhesion of monocytes: Relevance to heart disease in postmenopausal women

  2004cited by this paper
• Effects of chromium, and ascorbic acid supplementation on growth, carcass traits, serum metabolites, and antioxidant status of broiler chickens reared at a high ambient temperature (32°C)

  2003cited by this paper
• Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice.

  2003cited by this paper
• Role of CD36 in membrane transport of long-chain fatty acids

  2002cited by this paper
• Cytotoxicity and oxidative mechanisms of different forms of chromium.

  2002cited by this paper
• Fatty acid transport across membranes: relevance to nutrition and metabolic pathology.

  2002cited by this paper
• III. Peroxisomal β-oxidation, PPARα, and steatohepatitis

  2001cited by this paper
• Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis.

  2001cited by this paper
• A comparison of the in vitro genotoxicity of tri- and hexavalent chromium.

  2000cited by this paper
• Steatohepatitis: a tale of two "hits"?

  1998cited by this paper
• Chromium as an essential nutrient for humans.

  1997cited by this paper
• Chromium Deficiency Might Contribute to Insulin Resistance, Type 2 Diabetes Mellitus, Dyslipidaemia, and Atherosclerosis

  1996cited by this paper
• The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes.

  1992cited by this paper
• Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O

  1992cited by this paper
• Nonalcoholic fatty liver disease.

  1986cited by this paper

• Association between blood chromium and hepatic steatosis assessed by liver ultrasound transient elastography: National Health and Nutrition Examination Survey 2017–2020

  2024cites this paper
• A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH

  2022cites this paper
• Curcumin Improved Glucose Intolerance, Renal Injury, and Nonalcoholic Fatty Liver Disease and Decreased Chromium Loss through Urine in Obese Mice

  2021cites this paper
• CD36 and DGAT2 facilitate the lipid-lowering effect of chitooligosaccharides via fatty acid intake and triglyceride synthesis signaling.

  2021cites this paper
• Dietary supplemental chromium and niacin influence the growth performance and fat deposition in lambs

  2020cites this paper
• A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.

  2020cites this paper
• Aspirin Causes Lipid Accumulation and Damage to Cell Membrane by Regulating DCI1/OLE1 in Saccharomyces cerevisiae

  2020cites this paper
• Influence of chromium citrate on oxidative stress in the tissues of muscle and kidney of rats with experimentally induced diabetes

  2019cites this paper
• Chitooligosaccharide supplementation prevents the development of high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in mice via the inhibition of cluster of differentiation 36 (CD36)

  2019cites this paper
• Importance of Chromium in the Diet

  2019cites this paper
• Influence of Chronic Toxicity, Lipid Metabolism, Learning and Memory Ability, and Related Enzyme in Sprague-Dawley Rats by Long-Term Chromium Malate Supplementation

  2018cites this paper
• Differential capability of metabolic substrates to promote hepatocellular lipid accumulation

  2018cites this paper
• Chromium malate alleviates high-glucose and insulin resistance in L6 skeletal muscle cells by regulating glucose uptake and insulin sensitivity signaling pathways

  2018cites this paper
• Physiological responses of Chinese hamster ovary cells to a productivity-enhancing yeast extract.

  2018cites this paper
• Trivalent Chromium Supplementation Ameliorates Oleic Acid-Induced Hepatic Steatosis in Mice

  2018cites this paper
• Artemisinin Reduces Lipid Accumulation in Hepatocytes by Inhibition of CD36 Expression

  2017cites this paper